Life-science briefing: Friday, April 11, 2008

Life-science briefing: Friday, April 11, 2008

TODAY’S HEADLINES:

Stent maker IDev Tech raises $25M (VentureWire)
Xytis gets $15M for brain-injury drugs (VentureWire)
Diagnostic maker Iris Biotech plans to go public, launch breast-cancer test (Edgar)
RiverVest Venture Partners raises $75M life-science fund (release)
Concentric Medical names Maria Sainz CEO (release)

[Note: I’m a little sad to announce that this will… Continue Reading

Life-science briefing: Friday, April 4, 2008

TODAY’S HEADLINES:

IlluminOss Medical gets $11M for bone-fracture devices (peHUB)
Contract researcher Crown Bioscience takes in funding (release)

IlluminOss Medical gets $11M for bone-fracture devices — East Providence, R.I.-based IlluminOss Medical, a medical-device startup, raised $11 million in a second funding round, peHUB reports. Backers included New Leaf… Continue Reading

Life-science briefing: Thursday, April 3, 2008

Life-science briefing: Thursday, April 3, 2008

TODAY’S HEADLINES:

Mirna Thera spins out of Asuragen with $3M (release)
Stroke-therapy startup CoAxia raises $12M (release)
Stealthy device maker Synvascular gets $6.5M (peHUB)
AndroScience seeks $3.5M for anti-testosterone drugs (VentureWire)
Austria’s ProtAffin takes in €1.1M grant (release)
Singapore’s Moleac receives $3.5M for Chinese medicine (release)
Alethia Bio gets C$2.4M for antibody… Continue Reading

Life-science briefing: Monday, March 31, 2008

Life-science briefing: Monday, March 31, 2008

TODAY’S HEADLINES:

Boston Scientific spinout TriVascular2 takes in $65M (release)
Inhaled-drug startup Transave raises $35M (release)
Triage Wireless gets $20M for vital-signs monitors (release)
Tryton Medical receives $14M for “bifurcation” stents (release)

Synthetic bio startup Codon Devices adds $11M (release)
Tracon Pharma takes in $4.5M against cancer and eye disease (VentureWire)
Antibody maker… Continue Reading

Life-science briefing: Thursday, March 27, 2008

Life-science briefing: Thursday, March 27, 2008

TODAY’S HEADLINES:

Breathe Tech raises $15M for respiratory disease (release)
Protein-drug maker Pieris takes in €25M (release)
Apthera takes in $2.1M toward cancer vaccine (VentureWire)

Breathe Tech raises $15M for respiratory disease – Breathe Technologies, a Fremont, Calif., medical device maker, raised $15 million in a second round of funding…. Continue Reading

Life-science briefing: Wednesday, March 26, 2008

Life-science briefing: Wednesday, March 26, 2008

TODAY’S HEADLINES:

OptiMedica takes in $16M for eye-treatment lasers (release)
Genome analyzer BioNanomatrix raises $5M (release)
Heart diagnostic startup Aviir gets another $1.5M (VBLS exclusive)
Pharmaca, integrative-pharmacy chain, draws $20M (release)
LifeWatch, cardiac-monitoring device maker, withdraws IPO (IPOhome)
Jerry DeVries, Steven Whitlock join PTV Sciences as venture partners (VentureWire)

OptiMedica takes… Continue Reading

Life-science briefing: Tuesday, March 25, 2008

Life-science briefing: Tuesday, March 25, 2008

TODAY’S HEADLINES:

Antibody-discovery startup Adimab raises new funding (release)
Lung-device maker Spiration gets $19M (release)
Sample-prep startup Protein Discovery pulls in $10M (release)
Inogen takes in $13M for portable oxygen device (VentureWire)
Healthcare IT concern Medaptus raises $11M for expansion (VentureWire)
Contract lab Synexis raises $14M (peHUB)
Medical-device VC firm BioStar Ventures takes… Continue Reading

Life-science briefing: Thursday, March 20, 2008

Life-science briefing: Thursday, March 20, 2008

TODAY’S HEADLINES:

Vantia Thera spins out of Ferring, raises £19M (PDF release)
Third Eye gets $150K for intracranial-pressure monitor (release)
Diabetes tester Oculir closes doors, returns capital (VentureWire)
Catalyst Health Ventures raising $60M fund (VentureWire)

Vantia Thera spins out of Ferring, raises £19M – Vantia Therapeutics, a U.K. spinout of Ferring… Continue Reading

Life-science briefing: Wednesday, March 19, 2008

Life-science briefing: Wednesday, March 19, 2008

TODAY’S HEADLINES:

Paris-based Stentys takes $18M for “bifurcated” stents (release)
Blood analyzer IntelliDx raises $22M (PDF release)
Cancer-test biotech Calderome changes name to VeraCyte (VentureWire)
Predictive Biosciences names Peter Klemm as CEO (release)

Paris-based Stentys takes $18M for “bifurcated” stents – Stentys, a Paris-based medical device maker, raised $18 million in… Continue Reading

Life-science briefing: Tuesday, March 18, 2008

Life-science briefing: Tuesday, March 18, 2008

TODAY’S HEADLINES:

Luminous Medical raises $24M for automated glucose monitoring (release)
Alimera Sciences gets $30M for eye-disease drug (release)
Vaccine maker LigoCyte draws $28M (release)
Heartbeat tracker CardioNet trims IPO, aims for listing today (IPOhome)
Axial Biotech takes in $6M for spinal diagnostics (release)
Insulin bioengineer enGene receives $6.4M (release)
GlucoLight raises… Continue Reading

Vessel-clog remover Chestnut pulls in $7.8M

Vessel-clog remover Chestnut pulls in $7.8M

Chestnut Medical Technologies, a Menlo Park, Calif., medical-device maker, raised $7.8 million against an anticipated $10 million third funding round, I’ve learned. An SEC document (PDF link) the company filed with the California Department of Corporations disclosed the funding.

Chestnut makes a device best described as… Continue Reading

Miramar Labs gets $20M for “aesthetic” devices

Miramar Labs (no Web site), a Menlo Park, Calif., medical-device maker, raised $20.3 million in a second funding round, I’ve learned. There isn’t a huge amount of public information about the company, although it appears that the company is working on electromechanical devices of some… Continue Reading

Nellix raises $6.5M for aneurysm grafts

Nellix raises $6.5M for aneurysm grafts

Nellix Endovascular, a Palo Alto, Calif., medical-device maker, raised $6.5 million in a third funding round, I’ve learned. The startup is developing a new treatment for repairing blood-vessel flaws in the chest and abdomen.

Those flaws, known as aneurysms, are thin-walled “bubbles” in blood vessels that… Continue Reading

Defibrillator maker Cameron Health takes in $14M

Defibrillator maker Cameron Health takes in $14M

Cameron Health, a San Clemente, Calif., medical-device maker, has raised $14.1 million of a planned $50 million fifth funding round, I’ve learned. The company is working on a new type of implantable defibrillator that’s designed to be easier to implant and program than existing models.

Implantable… Continue Reading

Life-science briefing: Thursday, March 13, 2008

Life-science briefing: Thursday, March 13, 2008

TODAY’S HEADLINES:

Aperio Tech raises $20M for digital pathology (release)
TissueLink changes name, files for $86M IPO (Edgar)
Specialty pharma Cydex files to raise $50M in IPO (Edgar)
Hydra Biosciences takes in $34M for pain drugs (VentureWire)
AVI BioPharma acquires Ercole Biotech for $9M (release)
Juvaris Bio names Grant Pickering as CEO… Continue Reading

Life-science briefing: Friday, March 7, 2008

Life-science briefing: Friday, March 7, 2008

TODAY’S HEADLINES:

Allegro pulls in $4M for lung-cancer molecular diagnostics (release)
Ocular bandage developer I-Therapeutix raises $6M (Mass High Tech)
NanoBio gets last of $30M for skin-infection drugs (release)
Cayenne Medical raises $15M for sports medicine (release)
Aridis Pharma seeks $10M for oral-form drugs and vaccines (VentureWire)
Neurosurgical device maker Nfocus… Continue Reading

Life sciences briefing: Wednesday, March 5, 2008

Life sciences briefing: Wednesday, March 5, 2008

TODAY’S HEADLINES:

Precision Thera merger with “blank check” Oracle Healthcare collapses (release)
Sleep Solutions takes in $21M for sleep-apnea diagnostics (release)

Trevena takes in $24M for drugs targeting G-proteins (release)
“Specialty biotech” PanGenetics gets €23M for antibody drugs (release)
Cancer-drug maker Unibioscreen pulls in €5M (release)
Danish contract manufacturer CMC Biologics… Continue Reading

Life sciences briefing: Monday, March 3 ,2008

Life sciences briefing: Monday, March 3 ,2008

TODAY’S HEADLINES:

InfraReDx takes $17M for arterial-plaque detection (VentureWire)
Cancer-drug developer Serenex sells out to Pfizer for undisclosed sum (release)
Life-sciences fund Longitude Capital raises $95M (VentureWire)
Hospital consultant Intercede Health names Gray Miller as CEO (release)

InfraReDx takes $17M for arterial-plaque detection – InfraReDx, a Burlington, Mass., developer of diagnostic… Continue Reading

Life sciences briefing: Thursday, Feb. 28, 2008

Life sciences briefing: Thursday, Feb. 28, 2008

TODAY’S HEADLINES:

RNAi developer PhaseRx gets $4M of a pledged $19M (Seattle Times)
TyRx Pharma, drug-device combo maker, raises $25M (release)
Agennix aims at $40M for cancer drugs (VentureWire)
Starr Life Sciences goes after $1.6M for small-animal vital-signs scanner (VW)
CardioNet sets IPO terms, aims to raise $96M (IPOhome)

RNAi developer… Continue Reading

InSound Medical takes in $11M for “invisible” hearing aids — albeit ones that have been on the shelf for a while

InSound Medical takes in $11M for “invisible” hearing aids — albeit ones that have been on the shelf for a while

InSound Medical, a medical-device startup in Newark, Calif., wants to let people with hearing loss regain that sense without having to wear a conspicuous hearing aid. Instead of clipping around the ear or fitting precariously into the opening of the auditory canal, the company’s Lyric… Continue Reading